<- Go Home
Biopsys Medical, Inc.
As of July 31, 1997, Biopsys Medical, Inc. was acquired by Johnson & Johnson. Biopsys Medical, Inc. was engaged in the design, development, manufacture, and marketing of products for the diagnosis and management of breast cancer. The company's principal product, the Mammotome Biopsy System, was a less-invasive alternative to open surgical biopsy.
Market Cap
$268.9M
Volume
83.2K
Cash and Equivalents
$6.5M
EBITDA
-$1.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.6M
Profit Margin
56.60%
52 Week High
$34.75
52 Week Low
$13.00
Dividend
N/A
Price / Book Value
6.66
Price / Earnings
-911.76
Price / Tangible Book Value
6.66
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$2.1M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$21.8M
Debt
N/A
Equity
$40.3M
Revenue
$11.7M
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A